Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
On the Price of Valoctogene Roxaparvovec in Germany and Italy
On the Price of Valoctogene Roxaparvovec in Germany and Italy
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Lidia Staszewsky
,
Alessandro Nobili
,
Livio Garattini
,
Pier Mannuccio Mannucci
Format:
Artículo Open Access
Published:
Wiley
2025
Subjects:
Haemophilia
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Be the first to leave a comment!
Your Comment
You must be logged in first
Similar Items
Low‐dose emicizumab for more equitable access to prophylaxis in resource limited countries
by: Pier Mannuccio Mannucci, et al.
Published: (2024)
Bleeding Episodes in Patients With Haemophilia B Receiving Prophylactic Factor IX Treatment: A Systematic Review and Meta‐Analysis
by: Massimo Franchini, et al.
Published: (2025)
Final Analysis of the Phase 1/2 Trial of Valoctocogene Roxaparvovec for Severe Haemophilia A
by: Priyanka Raheja, et al.
Published: (2026)
Treatment With Valoctocogene Roxaparvovec in a Patient With Severe Hemophilia A Led to Sustained Normal FVIII Levels
by: Kerstin Herbst, et al.
Published: (2026)
Real‐world experience of rIX‐FP prophylaxis at dosing intervals of 14 days or more in adult patients with haemophilia B in Italy – Results from IDEAL Part B
by: Antonio Coppola, et al.
Published: (2024)